What is Thymox?
Thymox, operating under Laboratoire M2, is globally recognized for its innovative antimicrobial products, notably marketed under the Thymox brand. The company specializes in biodegradable disinfectants that are effective against a broad spectrum of pathogens, including bacteria, fungi, molds, and viruses like COVID-19. Their product line serves diverse sectors such as animal health, agricultural crop protection, and hard surface disinfection. A key component of their formulations is thymol, an active ingredient derived from thyme oil. Thymox offers a variety of solutions, including all-purpose disinfectants, farm-specific disinfectants, and biopesticides, positioning itself as a leader in eco-friendly solutions. The company is also actively seeking distributors and co-innovators to expand its sustainable product offerings.
How much funding has Thymox raised?
Thymox has raised a total of $4.6M across 1 funding round:
Series B
$4.6M
Series B (2017): $4.6M with participation from Desjardinsu2013Innovatech and Cycle Capital Management
Key Investors in Thymox
Desjardins-Innovatech
Desjardins-Innovatech is part of the Desjardins Group, a major Canadian cooperative financial institution known for its strong banking presence and commitment to innovation. Their investment likely supports companies with significant growth potential and a focus on technological advancement.
Cycle Capital Management
Cycle Capital Management is a venture capital firm specializing in clean technology and deep tech innovation. Their investment in Thymox suggests a focus on sustainable and environmentally friendly solutions within the biotechnology and disinfection sectors.
What's next for Thymox?
The recent major strategic investment indicates Thymox is likely in a growth or scaling phase, potentially leveraging this capital for market expansion, product development, or strengthening its distribution networks. The company's focus on biodegradable and effective antimicrobial solutions aligns with increasing global demand for sustainable and health-conscious products. Future developments may involve broader adoption of their thymol-based formulations across new industries or geographical markets, further solidifying their position as an innovator in green disinfection technologies.
See full Thymox company page
